Home > News > Biophage Pharma appoints Dr. Pearl Chin to Board of Directors
October 4th, 2005
Biophage Pharma appoints Dr. Pearl Chin to Board of Directors
Biophage Pharma is pleased to announce the appointment of Dr. Pearl Chin to its Board of Directors. Dr.
Chin is the founder and managing Director of Seraphima Ventures, a private equity fund focused on Nanotechnology.
Picosun patents ALD nanolaminate to prevent electronics from overheating September 28th, 2016
Leti and Taiwanese Tech Organizations Sponsoring Workshop in Taipei on MEMS, IoT, Smart Lighting Applications, System Reliability & Security September 28th, 2016
Fighting cancer with sticky nanoparticles September 27th, 2016
Gold nanoparticles conjugated quercetin inhibits epithelial-mesenchymal transition, angiogenesis and invasiveness via EGFR/VEGFR-2 mediated pathway in breast cancer September 27th, 2016
Dr Barbara Armbruster promoted to Worldwide Sales and Marketing Director for XEI Scientific September 27th, 2016
Dr Barbara Armbruster joins XEI Scientific as Marketing Director June 1st, 2016
Park Systems Global Expansion in AFM Market Includes Appointment of New Executives April 23rd, 2016
GLOBALFOUNDRIES Adds Alain Mutricy as Head of Product Management Group March 3rd, 2016